Wednesday, October 14, 2026

SPS Commerce, Inc. And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team

December 14, 2020

SPS Commerce, Inc. And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Home Depot

14.7% sales growth and 5514.35% return on equity

The Home Depot, Inc. operates as a home improvement retailer.

Home Depot sales growth this year is expected to be 17.8% and 0.8% for next year.

Year-on-year quarterly revenue growth grew by 23.2%, now sitting on 125.63B for the twelve trailing months.

Home Depot's sales growth for the next quarter is 14.7%. The company's growth estimates for the current quarter and the next is 12.3% and 35.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5514.35%.

Home Depot's Stock Top and Bottom Yearly Value

Home Depot's stock is valued at $264.51 at 22:57 EST, below its 52-week high of $292.95 and way higher than its 52-week low of $140.63.

Home Depot's Moving Average

Home Depot's worth is under its 50-day moving average of $273.43 and under its 200-day moving average of $268.74.

2. SPS Commerce, Inc.

10.8% sales growth and 11.16% return on equity

SPS Commerce, Inc. provides cloud-based supply chain management solutions worldwide.

SPS Commerce, Inc. sales growth this year is expected to be 11% and 9.6% for next year.

Year-on-year quarterly revenue growth grew by 12.2%, now sitting on 302.06M for the twelve trailing months.

SPS Commerce, Inc.'s sales growth for the next quarter is 10.8%. The company's growth estimates for the present quarter and the next is a negative 2.9% and negative -2.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.16%.

SPS Commerce, Inc.'s Stock Top and Bottom Yearly Value

SPS Commerce, Inc.'s stock is valued at $99.11 at 22:57 EST, below its 52-week high of $104.99 and way above its 52-week low of $31.28.

SPS Commerce, Inc.'s Moving Average

SPS Commerce, Inc.'s value is above its 50-day moving average of $91.89 and way above its 200-day moving average of $79.41.

3. Logitech International S.A.

20.7% sales growth and 46.66% return on equity

Logitech International S.A.

Logitech International S.A. sales growth this year is anticipated to be 37.8% and a negative 0.3% for next year.

Year-on-year quarterly revenue growth grew by 74.7%, now sitting on 3.66B for the twelve trailing months.

Logitech International S.A.'s sales growth is a negative 0% for the current quarter and 20.7% for the next. The company's growth estimates for the current quarter and the next is 20.2% and 21.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 46.66%.

Logitech International S.A.'s Stock Top and Bottom Yearly Value

Logitech International S.A.'s stock is valued at $89.79 at 22:57 EST, under its 52-week high of $95.71 and way higher than its 52-week low of $31.37.

Logitech International S.A.'s Moving Average

Logitech International S.A.'s worth is above its 50-day moving average of $85.72 and way above its 200-day moving average of $74.17.

4. T

70.2% sales growth and 5.95% return on equity

T-Mobile US, Inc., through its subsidiaries, provides wireless services for branded postpaid and prepaid, and wholesale customers in the United States, Puerto Rico, and the United States Virgin Islands.

T sales growth this year is anticipated to be 50.3% and 15.1% for next year.

Year-on-year quarterly revenue growth grew by 74.2%, now sitting on 59.93B for the twelve trailing months.

T's sales growth for the next quarter is 70.2%. The company's growth estimates for the present quarter and the next is a negative 43.7% and negative -42.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.95%.

T's Stock Top and Bottom Yearly Value

T's stock is valued at $131.23 at 22:57 EST, under its 52-week high of $134.24 and way higher than its 52-week low of $63.50.

T's Moving Average

T's value is above its 50-day moving average of $123.77 and way higher than its 200-day moving average of $113.13.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,372 source documents archived
Query this data → isubstrate.com